MMU banner 1

Tag: CAP7

JC: Oxygen in ACS. A fuss about nothing? The DETO2X Trial at St.Emlyn’s

DETO2X-SWEDEHEART sounds like a new low-carb, high-alkali, So-Cal diet plan but it is actually a trial exploring the affect of oxygen on mortality in patients with a suspected acute coronary syndrome (ACS). There is a

The Argument for Systemic Thrombolytics in Submassive Pulmonary Embolism. Swami at St.Emlyn’s

On June 15th 2016, I delivered an 8 minute talk arguing that we strongly consider the administration of systemic thrombolytics in patients with submassive pulmonary embolism at SMACCDub. This talk became infamous not for the

One high sensitivity troponin test to rule out acute myocardial infarction

This month I was honoured that a study I wrote with some terrific colleagues from Europe, Australia and the US has been published as the ‘Editor’s Choice’ in Academic Emergency Medicine. This was a secondary analysis

Life and Learning from Rob Rogers on the other side of that ECG. St.Emlyn’s

Last week I was  wandering through Amsterdam when I came across a tweet which stopped me in my tracks. A real game changer, a shock, a wake up call and a surprise. Rob Rogers (aka

Getting your chest pain evaluation right: #UMECS16

Last week, while Iain was giving a keynote lecture in Austria, I was also heading for distant shores to speak about chest pain evaluation at a special conference set up by the legendary Amal Mattu:

JC: High sensitivity Troponin I on presentation. Is it enough to rule out ACS? St.Emlyn’s

As you surely know we love thinking about Troponin at St.Emlyn’s. We have our own world expert in Rick Body and there is loads of stuff here on the site about the use (and abuse)

JC: Are typical chest pain symptoms predictive of outcome? St.Emlyn’s

We love a bit of meta-cognition here at St.Emlyn’s. As time passes and we all become a little longer in the tooth it becomes increasingly apparent that it’s not just ‘what’ we know it’s how

Good times part 1: DIDO-30 for STEMI

STEMI is one of the true medical emergencies.  We all know that the sooner our patient gets revascularisation, the better they do.  We’ve known this for years.  In a very nice meta-analysis, Eric Boersma showed

The MACS rule: a new user-friendly version

This blog post is based on a paper we’ve just had published in the Emergency Medicine Journal entitled: ‘The Manchester Acute Coronary Syndromes (MACS) decision rule: validation with a new automated assay for heart-type fatty